Neeraj Agarwal/primeinc.org
Jun 1, 2025, 16:11
Neeraj Agarwal Highlights STELLAR-002 Results in ccRCC at ASCO 2025
Neeraj Agarwal, Postdoctoral fellow at City of Hope, posted on X:
“Congrats Jad Chahoud on the terrific talk About 4515 at ASCO25.
Phase 1b STELLAR-002 study of zanzalintinib + nivo +/- relatlimab in pts with ccRCC.
ORR 63% w/ zanza+nivo (adding relatlimab does not help), key takeaway.”
More posts featuring ASCO25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 2, 2025, 18:07
Jun 2, 2025, 18:00
Jun 2, 2025, 17:43
Jun 2, 2025, 17:18
Jun 2, 2025, 17:06
Jun 2, 2025, 15:40